Trial · NCT01328756
Results by group27
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 27
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With All Treatment-Emergent Adverse Events (TEAEs) and Serious TEAEs | Lisdexamfetamine Dimesylate | Any TEAE | 282 | participants | |
| Number of Participants With All Treatment-Emergent Adverse Events (TEAEs) and Serious TEAEs | Lisdexamfetamine Dimesylate | Serious TEAE | 28 | participants | |
| Change From Baseline in Pulse Rate at Last On-treatment Assessment (LOTA) | Lisdexamfetamine Dimesylate | 7 | Standard Deviation 11.6 | beats per minute | |
| Change From Baseline in Sitting Diastolic Blood Pressure (DBP) at Last On-treatment Assessment (LOTA) | Lisdexamfetamine Dimesylate | 3.2 | Standard Deviation 9.05 | mmHg | |
| Change From Baseline in Sitting Systolic Blood Pressure (SBP) at Last On-treatment Assessment (LOTA) | Lisdexamfetamine Dimesylate | 3.4 | Standard Deviation 10.33 | mmHg | |
| Change From Baseline in Body Weight at Last On-treatment Assessment (LOTA) | Lisdexamfetamine Dimesylate | 2.1 | Standard Deviation 5.83 | kilogram(s) | |
| Change From Baseline in Height at Last On-treatment Assessment (LOTA) | Lisdexamfetamine Dimesylate | 6.1 | Standard Deviation 4.9 | centimeter(s) | |
| Change From Baseline in Body Mass Index (BMI) at Last On-treatment Assessment (LOTA) | Lisdexamfetamine Dimesylate | -0.5 | Standard Deviation 1.72 | kilogram per square meter | |
| Change From Baseline in Heart Rate at Last On-treatment Assessment (LOTA) | Lisdexamfetamine Dimesylate | 7.1 | Standard Deviation 13.51 | beats per minute | |
| Change From Baseline in QT Interval at Last On-treatment Assessment (LOTA) | Lisdexamfetamine Dimesylate | -10.3 | Standard Deviation 23.53 | milliseconds | |
| Change From Baseline in QT Interval Corrected Using Fridericia's Formula (QTcF) at Last On-treatment Assessment (LOTA) | Lisdexamfetamine Dimesylate | -0.6 | Standard Deviation 15.24 | milliseconds | |
| Change From Baseline in Brief Psychiatric Rating Scale for Children (BPRSC) Total Scores at Last On-treatment Assessment (LOTA) | Lisdexamfetamine Dimesylate | -10.3 | Standard Deviation 9.64 | scores on a scale | |
| Change From Baseline in the Attention-Deficit/Hyperactivity Disorder Rating Scale-IV (ADHD-RS-IV) Total Score at Last On-treatment Assessment (LOTA) | Lisdexamfetamine Dimesylate | -25.8 | Standard Deviation 11.1 | Scores on a scale | |
| Number of Participants With Clinical Global Impression-Global Improvement (CGI-I) at Last On-treatment Assessment (LOTA) | Lisdexamfetamine Dimesylate | Very much improved | 141 | participants | |
| Number of Participants With Clinical Global Impression-Global Improvement (CGI-I) at Last On-treatment Assessment (LOTA) | Lisdexamfetamine Dimesylate | Much improved | 92 | participants | |
| Number of Participants With Clinical Global Impression-Global Improvement (CGI-I) at Last On-treatment Assessment (LOTA) | Lisdexamfetamine Dimesylate | Minimally improved | 28 | participants | |
| Number of Participants With Clinical Global Impression-Global Improvement (CGI-I) at Last On-treatment Assessment (LOTA) | Lisdexamfetamine Dimesylate | No change | 20 | participants | |
| Number of Participants With Clinical Global Impression-Global Improvement (CGI-I) at Last On-treatment Assessment (LOTA) | Lisdexamfetamine Dimesylate | Minimally worse | 13 | participants | |
| Number of Participants With Clinical Global Impression-Global Improvement (CGI-I) at Last On-treatment Assessment (LOTA) | Lisdexamfetamine Dimesylate | Much worse | 5 | participants | |
| Number of Participants With Clinical Global Impression-Global Improvement (CGI-I) at Last On-treatment Assessment (LOTA) | Lisdexamfetamine Dimesylate | Very much worse | 0 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01328756/results